Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Hisse Senetlerindeki Sıralama
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Hisse Fiyatı
$20.91
Piyasa Değeri
$7.57B
Değişim (1 gün)
-8.26%
Değişim (1 yıl)
41.25%
Ülke
CN
Ticaret Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Kategori
Healthcare
Asymchem Laboratories (Tianjin) Co., Ltd. (002821) için kazanç
Jun 2026 itibarıyla kazanç TTM: $175.62M
Asymchem Laboratories (Tianjin) Co., Ltd. şirketinin en son finansal raporlarına göre, mevcut kazancı $175.62M'dir. 2024 yılında şirket $146.92M kazanç elde etti, bu 2023 yılındaki $361.25M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Asymchem Laboratories (Tianjin) Co., Ltd. için kazanç geçmişi 2011 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2026 (TTM) | $175.62M | -4.48% |
| 2025 | $183.86M | 25.15% |
| 2024 | $146.92M | -59.33% |
| 2023 | $361.25M | -33.10% |
| 2022 | $540.01M | 187.71% |
| 2021 | $187.69M | 51.14% |
| 2020 | $124.18M | 38.67% |
| 2019 | $89.55M | 33.73% |
| 2018 | $66.96M | 3.22% |
| 2017 | $64.87M | 38.39% |
| 2016 | $46.88M | 52.55% |
| 2015 | $30.73M | 43.65% |
| 2014 | $21.39M | 28.73% |
| 2013 | $16.62M | 23.63% |
| 2012 | $13.44M | -5.39% |
| 2011 | $14.21M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| $5.27B | 2,903.53% |
US
|
|
| $-3.09B | -1,857.74% |
US
|
|
| $-4.02B | -2,386.83% |
AU
|
|
| $2.85B | 1,520.36% |
BE
|
|
| $1.95B | 1,010.70% |
NL
|
